Evidence map›Paper›PMID 41848323›Full record

ArticleMicrobiology spectrum2026

Engineered antimicrobial-derived peptides to manipulate mixed microbial systems.

Vikas D Trivedi, James A Van Deventer, Nikhil U Nair

Abstract read
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Vikas D TrivediDepartment of Chemical and Biological Engineering, Tufts University, Medford, Massachusetts, USA.
James A Van DeventerDepartment of Chemical and Biological Engineering, Tufts University, Medford, Massachusetts, USA.
Nikhil U NairDepartment of Chemical and Biological Engineering, Tufts University, Medford, Massachusetts, USA.ORCID 0000-0001-7737-1385

Funding

Metabolic engineering in humans: Altered gut microbes as a therapeutic platformDP2HD091798 · NICHD · TUFTS UNIVERSITY MEDFORD · PI NAIR, NIKHIL UNNI · 2016 to 2016
$2.3M
National Science Foundation 1935354NIH HHS DP2HD091798Office of the Vice Provost for Research, Tufts University Tufts Launchpad Accelerator
6 · The paper itself

Abstract

Due to the complexity of microbial communities and coarseness of currently available manipulation techniques (e.g., transplantation and antibiotic treatment), it is often difficult to fully elucidate the interactions between members that define community structure and function from the top down. Thus, it is imperative to be able to observe and manipulate subpopulations within microbial communities to enable a fine-detail understanding of the full spectrum and mechanism of community functions. However, there is a technological gap that prevents targeted manipulation of subpopulations within intact microbial mixtures and communities. In this work, we develop molecular probes to manipulate specific subpopulations within multispecies microbial populations and validate these methods using model synthetic populations IMPORTANCE: We demonstrate a novel approach for top-down manipulation of microbial co-cultures by leveraging the narrow-spectrum activity of a class IIa bacteriocin (bacterial-derived antimicrobial peptide). We expect this approach to be applicable to other microbial communities/microbiota when expanded to other bacteriocins and may prove to be an invaluable tool in studying structure-function relationships in microbial communities and engineering them for a variety of applications.

Indexed as

Anti-Bacterial AgentsAntimicrobial PeptidesBacteriaBacteriocinsMicrobial Sensitivity TestsPediocinsAnti-Bacterial AgentsAntimicrobial PeptidesBacteriocinspediocin PA-1PediocinsAMPchemical biologyco-culturespeptidesynthetic ecologytop-down

Identifiers

PMID41848323
PMCPMC13055374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.